CLINICAL_TRIALS
trial_result
· 2021-02-17
Clinical Trial Update: Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc [Phase 4]
Summary
Phase 4 trial comparing injection site pain between semaglutide and dulaglutide in study participants; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2021-02-17